ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,343.09
-0.18%
US Tech 100
18,494.00
-0.22%
Dow Jones
38,822.19
-0.16%
Brent Oil
79.955
0.09%
Bitcoin
71,474.96
1.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Schrodinger Inc (SDGR) Quote

Schrodinger Inc

Schrodinger Inc (SDGR)

NASDAQ
22.7832
-0.6168
( -2.64% )
Updated: 09:31:32
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
22.7832
Bid
22.68
Ask
22.91
Volume
11,787
22.66 Day's Range 22.93
20.76 52 Week Range 59.24
Market Cap
1.649B
Previous Close
23.40
Open
22.93
Last Trade
200
@
22.7832
Last Trade Time
09:31:32
Financial Volume
$ 269,924
VWAP
22.9001
Average Volume (3m)
739,290
Shares Outstanding
72,310,612
Dividend Yield
-
PE Ratio
40.49
Earnings Per Share (EPS)
0.56
Revenue
216.67M
Net Profit
40.72M

About Schrodinger Inc

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.schrodinger.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was $23.40. Over the last year, Schrodinger shares have traded in a share price range of $ 20.76 to $ 59.24.

Schrodinger currently has 72,310,612 shares outstanding. The market capitalization of Schrodinger is $1.65 billion. Schrodinger has a price to earnings ratio (PE ratio) of 40.49.

Schrodinger (SDGR) Options Flow Summary

SDGR Options Flow

Overall Flow

Bearish

Net Premium

-2M

Calls / Puts

0.00%

Buys / Sells

133.33%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

SDGR Latest News

More News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 30 2024
Edgar (US Regulatory)

Schrödinger to Present at Jefferies Global Healthcare Conference

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a...

May 22 2024
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on May 16, 2024, the company...

May 17 2024
Business Wire

Schrödinger Reports First Quarter 2024 Financial Results

First Quarter Total Revenue of $36.6 Million, Software Revenue of $33.4 Million Announces FDA Clearance of Investigational New Drug Application for SGR-3515, a Novel Wee1/Myt1 Inhibitor SGR-1505...

May 01 2024
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company...

April 18 2024
Business Wire

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2024 financial results on...

April 10 2024
Business Wire

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its...

March 20 2024
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on March 15, 2024, the company...

March 19 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.87323.985394796921.9123.4721.1166330722.32478189CS
4-0.2468-1.0716456795523.0324.621.1164980022.49217985CS
12-2.7368-10.72413793125.5229.1521.1173929024.499011CS
26-8.7868-27.832752613231.573821.1182325427.4385019CS
52-15.8368-41.006732263138.6259.2420.7697172233.91616744CS
156-49.2168-68.35666666677279.7515.8577888934.61309665CS
260-7.6668-25.178325123230.4511715.8589818146.57205421CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.3499
(0.00%)
273
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.26
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.77
(0.00%)
229
AACIArmada Acquisition Corporation I
$ 11.46
(0.00%)
24
AACGATA Creativity Global
$ 0.888
(0.00%)
13
AAGRAfrican Agriculture Holdings Inc
$ 0.3499
(0.00%)
273
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.26
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.77
(0.00%)
229
AACIArmada Acquisition Corporation I
$ 11.46
(0.00%)
24
AACGATA Creativity Global
$ 0.888
(0.00%)
13
FFIEFaraday Future Intelligent Electric Inc
$ 0.544
(0.00%)
38.83M
VEROVenus Concept Inc
$ 0.5867
(0.00%)
23.5M
CRKNCrown Electrokinetics Corporation
$ 0.0874
(0.00%)
21.24M
PRSTPresto Technologies Inc
$ 0.0759
(0.00%)
20.17M
GERNGeron Corp
$ 3.89
(0.00%)
12.57M

SDGR Discussion

View Posts
scotsand scotsand 8 months ago
This needs to turn around soon. So oversold.
👍️0
scotsand scotsand 1 year ago
Beast mode
👍️0
scotsand scotsand 1 year ago
Love this ticker
👍️0
scotsand scotsand 1 year ago
Up 20%. Guess was right… adding.
👍️0
scotsand scotsand 1 year ago
Now is the time to add.
👍️0
Porterhouse10 Porterhouse10 2 years ago
Cathy Woods adding
👍️0
nowwhat2 nowwhat2 3 years ago



👍️0
adtime adtime 3 years ago
This was a fun move hope someone followed ;) 8% at peak today ftw
👍️0
adtime adtime 3 years ago
Nice set up if gets into 60
👍️0
ernie44 ernie44 3 years ago
M and A -------------------------
merger looming---microsoft
👍️0
Bucketh3ad Bucketh3ad 4 years ago
Smh
👍️0
chrispy2468 chrispy2468 4 years ago
Any insight to this upward move after hours?
👍️0
canadiansalmongal canadiansalmongal 4 years ago
Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
👍️0
chrispy2468 chrispy2468 4 years ago
Little action AH
👍️0
RodgeDodger RodgeDodger 4 years ago
Still running
👍️0
crudeoil24 crudeoil24 4 years ago
I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
👍️0
realfast95 realfast95 4 years ago
yea he exaggerates his long ideas. TLRY,RVLV come to mind
👍️0
crudeoil24 crudeoil24 4 years ago
Citron > will they be shorting tomorrow? Playing off the TSLA hype!

👍️0
chrispy2468 chrispy2468 4 years ago
Bullish
👍️0
TheFinalCD TheFinalCD 4 years ago
https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
👍️0
realfast95 realfast95 4 years ago
Citron pump

https://twitter.com/CitronResearch/status/1230538195726503942

Citron Research
@CitronResearch
$SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

👍️0
RodgeDodger RodgeDodger 4 years ago
Still running
👍️0
crudeoil24 crudeoil24 4 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher

Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

The company has granted the underwriters an option to buy up to 1.78 million additional shares.
👍️0
crudeoil24 crudeoil24 4 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

👍️0

Your Recent History

NASDAQ
SDGR
Schrodinger
BIT
GEU3C
Exchange Traded
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved